Results 51 to 60 of about 2,259 (129)

Not all Mismatches Were Created Equal: Empirical Identification of Regions Within HLA-DQ Molecules That Harbor the Highest Immunogenicity. [PDF]

Transplantation
Matias EG, Austin DE, Franca KC, Maguire C, Lockhart JS, Lantz CW, Tambur AR.   +6 more
europepmc   +1 more source

Impact and outcomes after desensitization therapy in highly sensitized heart transplant candidates. [PDF]

Am J Transplant
Jain R, Nikolova A, Kittleson M, Kransdorf EP, Chang D, Deckerman P, Kobashigawa JA.   +6 more
europepmc   +1 more source

Marked platelet transfusion refractoriness caused by anti-HLA-I and anti-HPA-5b antibodies: A case report. [PDF]

Medicine (Baltimore)
Wang Y, Liu Z, Duan S, Lin C, Jin Y, Wang H, Wang Y, Tang L, Wang M.   +8 more
europepmc   +1 more source

Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays. [PDF]

HLA
Heinemann FM, Hallensleben M, Althaus K, Budde K, Einecke G, Eisenberger U, Ender A, Feldkamp T, Grahammer F, Guthoff M, Holzmann-Littig C, Hugo C, Kauke T, Kemmner S, Koch M, Lachmann N, Lindemann M, Morath C, Nitschke M, Renders L, Scherer S, Schlaf G, Stumpf J, Schwenger V, Sommer F, Spriewald BM, Süsal C, Verboom M, Zecher D, Ziemann M.   +29 more
europepmc   +1 more source

Ravulizumab stabilizes life-threating intravascular hemolysis following delayed hemolytic transfusion reaction due to alloantibodies anti-e and anti-Jka: the first successful administration. [PDF]

Ann Hematol
Bezirgiannidou Z, Stamatiou I, Theodoridis TM, Kontekaki E, Panagiotopoulos E, Misidou C, Vrachiolias G, Malkots B, Papoutselis M, Kotsianidis I, Spanoudakis E, Liapis K.   +11 more
europepmc   +1 more source

Multicenter evaluation of soluble CD38: neutralizing anti-CD38 pan-reactivity to enable alloantibody detection. [PDF]

Blood Transfus
Engström C, Scherrer E, Falconer J, Londero D, Penatejera C, Legoff I, Marchenay ND, Le Bouar M, Nocera C, Paesano L, De Martino S, Pettinelli ME, Caesar A, Bise T, Amniai L.   +14 more
europepmc   +1 more source

Revealing and quantifying polyclonal anti-A, B specificity in ABO histo-blood groups. [PDF]

Transfusion
Henry S, Perry H, Obukhova P, Tyrtysh T, Ryzhov I, Bovin N, Datta SS.   +6 more
europepmc   +1 more source

Development and validation of a risk prediction model and management strategy for red blood cell irregular antibodies a retrospective cohort study of 521 patients. [PDF]

Clin Exp Med
Wang L, Yang J, Guo Z, Qiu D, Fu Y, Xu Y.   +5 more
europepmc   +1 more source

Optimized strategy to mitigate daratumumab interference in blood bank testing: Reducing cost and time. [PDF]

Am J Clin Pathol
Yu T, Insigne A, Anushka W, Nedelcu E.
europepmc   +1 more source

Evaluation of dnDSA risk stratification using the updated PIRCHE-T2 model in two kidney transplant cohorts. [PDF]

Front Immunol
Tian Y, Niemann M, Matern BM, Frischknecht L, Mallone A, Rössler F, Schachtner T, Schaub S, Nilsson J.   +8 more
europepmc   +1 more source